bf/NASDAQ:CPRX_icon.jpeg

COM:CATALYSTPHARMA

Catalyst Pharmaceuticals, Inc.

  • Stock

Last Close

23.25

08/11 21:00

Market Cap

1.83B

Beta: -

Volume Today

1.49M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
500K
-
102.31M
20,361.27%
119.07M
16.39%
140.83M
18.27%
214.20M
52.10%
398.20M
85.90%
cost of revenue
14.76M
-
17.04M
15.45%
21.88M
28.43%
34.39M
57.16%
84.53M
145.78%
gross profit
500K
-
87.55M
17,409.44%
102.03M
16.55%
118.95M
16.58%
179.81M
51.17%
313.67M
74.45%
selling and marketing expenses
3.30M
-
23.57M
614.16%
26.15M
10.96%
29.47M
12.69%
86.69M
194.17%
general and administrative expenses
2.21M
-
4.47M
101.98%
8.60M
92.17%
7.91M
7.99%
7.30M
7.66%
15.88M
117.35%
33.58M
111.52%
20.67M
38.46%
23.48M
13.60%
28.71M
22.31%
47.02M
63.76%
selling general and administrative expenses
2.21M
-
4.47M
101.98%
8.60M
92.17%
7.91M
7.99%
7.30M
7.66%
15.88M
117.35%
36.88M
132.31%
44.23M
19.94%
49.63M
12.19%
58.18M
17.24%
133.71M
129.81%
research and development expenses
8.10M
-
10.12M
24.96%
11.80M
16.64%
11.37M
3.66%
11.38M
0.05%
19.92M
75.11%
18.84M
5.40%
16.50M
12.45%
16.94M
2.66%
19.79M
16.85%
93.15M
370.72%
other expenses
76.23K
-
100.39K
31.69%
321.61K
220.37%
454.16K
41.21%
1.29M
184.40%
1.59M
22.77%
586.90K
62.99%
282K
51.95%
2.88M
921.63%
7.70M
167.23%
cost and expenses
10.31M
-
14.59M
41.50%
20.40M
39.80%
19.28M
5.48%
18.68M
3.11%
35.80M
91.63%
70.48M
96.91%
77.77M
10.34%
88.45M
13.73%
112.36M
27.04%
311.39M
177.13%
operating expenses
10.31M
-
14.59M
41.50%
20.40M
39.80%
19.28M
5.48%
18.68M
3.11%
35.80M
91.63%
55.72M
55.67%
60.73M
8.98%
66.56M
9.61%
77.97M
17.14%
226.86M
190.95%
interest expense
47.42K
-
76.23K
60.76%
100.39K
31.69%
321.61K
220.37%
454.16K
41.21%
1.29M
184.40%
-4.12M
-
ebitda
-8.40M
-
-13.57M
61.58%
-20.46M
50.79%
-20.17M
1.45%
-18.49M
8.30%
-35.30M
90.86%
31.82M
190.16%
41.30M
29.79%
52.38M
26.83%
101.84M
94.40%
119.95M
17.79%
operating income
-10.31M
-
-14.59M
41.50%
-20.40M
39.80%
-19.28M
5.48%
-18.68M
3.11%
-35.30M
88.95%
31.82M
190.16%
41.30M
29.79%
52.38M
26.83%
101.84M
94.40%
86.81M
14.75%
depreciation and amortization
22.48K
-
26.57K
18.20%
34.47K
29.71%
43.41K
25.93%
45.69K
5.26%
37.98K
16.88%
297.73K
683.94%
885.32K
197.36%
192K
78.31%
1.24M
545.31%
33.14M
2,574.98%
total other income expenses net
-1.89M
-
-917.63K
51.46%
165.39K
118.02%
1.21M
630.23%
267.26K
77.87%
1.29M
383.30%
1.59M
22.77%
586.90K
62.99%
282K
51.95%
2.88M
921.63%
7.70M
167.23%
income before tax
-12.15M
-
-15.51M
27.60%
-20.23M
30.46%
-18.07M
10.68%
-18.41M
1.88%
-34.00M
84.68%
33.41M
198.25%
41.89M
25.39%
52.67M
25.73%
104.72M
98.83%
94.51M
9.75%
income tax expense
1.84M
-
993.87K
46.07%
-99.47K
110.01%
-929.54K
834.47%
141.22K
115.19%
2.58M
1,729.34%
1.53M
40.63%
-33.09M
2,257.72%
13.19M
139.84%
21.64M
64.13%
23.10M
6.75%
net income
-12.15M
-
-15.51M
27.60%
-20.23M
30.46%
-18.07M
10.68%
-18.41M
1.88%
-34.00M
84.68%
31.88M
193.74%
74.98M
135.24%
39.48M
47.35%
83.08M
110.42%
71.41M
14.05%
weighted average shs out
45.45M
-
64.14M
41.12%
80.86M
26.06%
82.88M
2.49%
85.80M
3.53%
102.63M
19.62%
102.94M
0.30%
103.51M
0.55%
103.38M
0.13%
103.37M
0.00%
106.28M
2.81%
weighted average shs out dil
45.45M
-
64.14M
41.12%
80.86M
26.06%
82.88M
2.49%
85.80M
3.53%
102.63M
19.62%
106.02M
3.30%
106.24M
0.21%
107.80M
1.46%
111.38M
3.32%
113.75M
2.13%
eps
-0.27
-
-0.24
11.11%
-0.25
4.17%
-0.22
12%
-0.21
4.55%
-0.33
57.14%
0.31
193.94%
0.72
132.26%
0.38
47.22%
0.80
110.53%
0.67
16.25%
epsdiluted
-0.27
-
-0.24
11.11%
-0.25
4.17%
-0.22
12%
-0.21
4.55%
-0.33
57.14%
0.30
190.91%
0.71
136.67%
0.37
47.89%
0.75
102.70%
0.63
16%

All numbers in (except ratios and percentages)